Improving HPV vaccination rates in underserved communities through communication campaigns
Official title: P30 Administrative Supplement for Multi-Channel Communication Campaigns for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations
Funded at University of Southern California · NIH-11142208 · Data updated 2026-11-12
This study is working to help more Hispanic, Latino, and African American teens get the HPV vaccine by sharing helpful information in ways that make sense to them, using social media and friends to spread the word.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project start | December 1, 2024 |
| Project end | November 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $200,000 |
| NIH project number | 3P30CA014089-48S2 |
| Project ID | NIH-11142208 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include adolescents and young adults aged 10-30 from Hispanic, Latino, and African backgrounds, particularly those with low health literacy regarding HPV.
✕Less likely to help
Patients who are already fully vaccinated against HPV or those outside the targeted age and demographic groups may not benefit from this research.
What this research studies
This research focuses on enhancing HPV vaccination rates among underserved populations, particularly Hispanic, Latino, and African adolescent groups. It aims to address low health literacy and misconceptions about the HPV vaccine through tailored communication strategies. The project will utilize multi-channel campaigns, including social media and peer-to-peer promotion, to disseminate culturally relevant educational materials. Additionally, artificial intelligence will be employed to adapt these materials to better resonate with the target audience.
Why it matters
Potential benefit: If successful, this research could significantly increase HPV vaccination rates and improve cancer prevention in underserved communities.
How similar studies have gone: Previous research has shown success in using tailored communication strategies to improve vaccination rates in similar underserved populations.
Where this research is happening
-
University of Southern California
Los Angeles, United States Active
Researchers
- Principal investigator: Lerman, Caryn — University of Southern California
- Study coordinator: Lerman, Caryn
Related research
Other NIH-funded projects on the same topics.
-
RNA dysregulation in a rare childhood brain disorder (PCH1b)
Researchers are studying a rare genetic brain disease in young children to understand how RNA processing goes wrong and leads to damage in the cerebellum and brainstem.
-
Studying how diverse signals come from similar molecules at glutamatergic synapses
A project at a university explores how synapses in the brain create different signals from a shared set of molecules, using a fruit-fly model to understand how this could relate to neurodevelopmental and neurodegenerative diseases.
-
How brain chemicals may influence tau clumps in Alzheimer’s disease
A study from USC explores how certain brain chemicals might influence the clumping of tau protein related to Alzheimer’s disease, aiming to identify factors that could affect disease progression.
-
GLP-1 medicines and brain health: real-world clues about dementia risk
A nationwide study will follow adults 21 and older using GLP-1 medicines to see how these drugs relate to memory, thinking, and dementia risk in real life.
-
Male pesticide exposure and reproductive health through epigenetics
This project looks at how a man’s exposure to pesticides might affect his fertility and the health of his future children through changes in DNA.
-
Global effort to harmonize fMRI findings in psychiatry
A large, international effort will standardize how brain MRI data are collected and analyzed in people with various mental health conditions to improve consistency and discovery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.